Back to search

Democritus University of Thrace (DUTH)

Διαταραχές κατά τον ύπνο σε ασθενείς με ιδιοπαθή πνευμονική ίνωση (ΙΠΙ) και συσχετισμός αυτών με παραμέτρους αναπνευστικής και καρδιαγγειακής λειτουργίας και με δείκτες ποιότητος ζωής

Abstract

dc:description

ABSTRACTIntroductionIdiopathic pulmonary fibrosis (IPF) is a diffuse parenchymal lung disease of unknown cause, associated with the histopathologic pattern of usual interstitial pneumonia (UIP). It is the most common form of the idiopathic interstitial pneumonias and has a poor prognosis. Ιn the absence of any effective treatment for IPF so far, the primary therapeutic goal should be the improvement of quality of life focusing on the recognition and treatment of co morbidities, such as sleep disorders.ObjectiveThe aim of this PhD thesis was to recognize sleep disorders and daytime consequences in newly diagnosed idiopathic pulmonary fibrosis (IPF) patients before the start of any of the commonly used IPF treatments and includes two studies. The first study was held at the sleep laboratory of Sismanogleion GH of Athens. At the second study patients were recruited from four pulmonary departments.Each study focuses on different parameters of sleep disorders.The aim of the first study was to describe sleep quality and associated daytime consequences in IPF.The aim of the second study was to assess the frequency of obstructive sleep apnea/ hypopnea syndrome (OSAHS) in newly diagnosed IPF patients and to identify possible correlations with body mass index and pulmonary function testing parameters.Materials and Methods of “Study 1”Fifteen patients with IPF and 15 control subjects matched on age and anthropometric variables were included in the study. Sleep quality and its daytime consequences were assessed by clinical interview, the Pittsburgh Sleep Quality Index (PSQI), the Functional Outcomes in Sleep Questionnaire (FOSQ), the Fatigue Severity Scale (FSS), the Epworth Sleepiness Scale and attended all-night polysomnography.Results of “Study 1”Polysomnography revealed a decrease in sleep efficiency and slow wave sleep, and an increase in stage 1 sleep and arousal index in IPF patients compared to controls. Daytime tachypnea persisted during sleep. Oxygen saturation below 90% was observed during 34.3 ± 37.3% of the total sleep time (TST). Quality of sleep and daytime function were moderately to significantly impaired based on the PSQI and FOSQ. The total FOSQ score was negatively correlated with TST with oxygen saturation below 90% (p = 0.01, r = –0.62). FSS scores were correlated with TST at oxygen saturation below 90% and mean oxygen saturation during sleep (p = 0.002, r = 0.74, and p = 0.007, r = –0.66, respectively). No statistically significant differences were found in the apnea-hypopnea index in IPF patients compared to controls (9.2 ±6.7 vs. 7.1 ±4.5, p=0.31, respectively). Albeit, 67% of IPF patients had an AHI > 5.Materials and methods of “Study 2”Thirty-four newly diagnosed IPF patients were included. All subjects underwent attended overnight PSG. None of the included subjects was under any of the currently available IPF treatments or nocturnal supplemental oxygen therapy.Results of “Study 2”Total apnea–hypopnea index (AHI) was <5, 5–15, and ≥15/h of sleep in 14 (41%), 15 (44%), and five patients (15%), respectively. REM AHI was statistically significant correlated with TLC [Total lung capacity] (p=0.03, r=−0.38). Diffusing capacity of the lung for carbon monoxide was correlated with mean oxygen saturation during sleep (p=0.02, r=0.39). On PSG was noted a decrease in sleep efficiency (64.9± 14.5%) and REM sleep (10.1±4.8%) and an increase in stage 1 sleep (15.1±7.7%) as well as inthe first study.ConclusionsTo the best of our knowledge these studies are among the first prospective studies investigating SDB in a newly diagnosed IPF population group before the start of any treatment and/or nocturnal oxygen therapy. Our data suggest significant sleep disruption and consequent impairment of physical and social functioning in patients with IPF. Significant correlations were observed between parameters of oxygen saturation during sleep and daytime functional status.In addition, it is demonstrated that the frequency of SDB is common in IPF patients, something that was controversial until recently. For the first time OSA is considered a comorbid condition frequently associated with IPF and research in the field is encouraged. If we stayed in the findings of the studies of the previous decades this would never happen.The questions that emerge after these conclusions are first of all if IPF patients should be routinely monitored for sleep disorders and secondly if IPF patients with OSAS should be treated with CPAP, in order to improve quality of sleep and as a consequence quality of life, as early recognition and treatment of sleep disturbances should be a primary therapeutic goal in the absence of effective treatments for IPF.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stagaki, Eleni
  • Σταγάκη, Ελένη

Subjects

dc:subject × 11

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35907

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stagaki, Eleni; Σταγάκη, Ελένη. Διαταραχές κατά τον ύπνο σε ασθενείς με ιδιοπαθή πνευμονική ίνωση (ΙΠΙ) και συσχετισμός αυτών με παραμέτρους αναπνευστικής και καρδιαγγειακής λειτουργίας και με δείκτες ποιότητος ζωής. Democritus University of Thrace (DUTH), 2015. http://hdl.handle.net/10442/hedi/35907